EP2968588
Samsetningar af samtengdu and-EGFR mótefni-lyfi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2014EP published:
9.1.2019EP application number:
14722450.5
EP translation filed:
8.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2024
Title:
ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS
Timeline
Today
14.3.2014EP application
9.1.2019EP Publication
8.4.2019Translation submitted
15.5.2019Registration published
13.3.2024Expires
Owner
Name:
Abbvie Deutschland GmbH & Co. KGAddress:
Max-Planck-Ring 2a, 65205, Wiesbaden, DE
Name:
AbbVie Inc.Address:
1 North Waukegan Road, 60064, North Chicago, IL, US
Inventor
Name:
TSCHOEPE, MarkusAddress:
Hessheim, DE
Name:
KALETA, KatharinaAddress:
Ludwigshafen, DE
Name:
KUMAR, VineetAddress:
Storrs, CT, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361790490 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 47/68, A61P 35/00, A61K 9/19
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 11.4.2019
Expires: 13.3.2020
Payer: Örn Þór, slf.
Number: 7
Paid: 14.2.2020
Expires: 13.3.2021
Payer: Örn Þór slf.
Number: 8
Paid: 10.2.2021
Expires: 13.3.2022
Payer: Örn Þór slf.
Number: 9
Paid: 15.2.2022
Expires: 13.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.